Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 86
Filtrer
1.
Article de Anglais | MEDLINE | ID: mdl-38865572

RÉSUMÉ

Hyalohyphomycosis and phaeohyphomycosis are groups of mycoses caused by several agents and show different clinical manifestations. We report a case of an immunocompromised patient who presented rare manifestations of opportunistic mycoses: mycetoma-like hyalohyphomycosis on his right foot caused by Colletotrichum gloeosporioides, followed by cutaneous phaeohyphomycosis on his right forearm caused by Exophiala oligosperma. Further to the rarity of this case, the patient's lesion on the foot shows that the clinical aspects of mycetomas could falsely appear in other fungal infections similar to hyalohyphomycosis. We also show that the muriform cells that were seen in the direct and anatomopathological examination of the skin are not pathognomonic of chromoblastomycosis, as observed in the lesion of the patient's forearm.


Sujet(s)
Chromoblastomycose , Mycétome , Humains , Mâle , Chromoblastomycose/anatomopathologie , Chromoblastomycose/diagnostic , Chromoblastomycose/microbiologie , Chromoblastomycose/traitement médicamenteux , Mycétome/anatomopathologie , Mycétome/microbiologie , Mycétome/diagnostic , Mycétome/traitement médicamenteux , Diagnostic différentiel , Sujet immunodéprimé , Hyalohyphomycose/anatomopathologie , Hyalohyphomycose/microbiologie , Hyalohyphomycose/diagnostic , Exophiala/isolement et purification , Adulte d'âge moyen
2.
PLoS One ; 19(2): e0297232, 2024.
Article de Anglais | MEDLINE | ID: mdl-38354109

RÉSUMÉ

Exophiala is a black fungi of the family Herpotrichiellaceae that can be found in a wide range of environments like soil, water and the human body as potential opportunistic pathogen. Some species are known to be extremophiles, thriving in harsh conditions such as deserts, glaciers, and polluted habitats. The identification of novel Exophiala species across diverse environments underlines the remarkable biodiversity within the genus. However, its classification using traditional phenotypic and phylogenetic analyses has posed a challenges. Here we describe a novel taxon, Exophiala chapopotensis sp. nov., strain LBMH1013, isolated from oil-polluted soil in Mexico, delimited according to combined morphological, molecular, evolutionary and statistics criteria. This species possesses the characteristic dark mycelia growing on PDA and tends to be darker in the presence of hydrocarbons. Its growth is dual with both yeast-like and hyphal forms. LBMH1013 differs from closely related species such as E. nidicola due to its larger aseptate conidia and could be distinguished from E. dermatitidis and E. heteromorpha by its inability to thrive above 37°C or 10% of NaCl. A comprehensive genomic analyses using up-to-date overall genome relatedness indices, several multigene phylogenies and molecular evolutionary analyzes using Bayesian speciation models, further validate its species-specific transition from all current Exophiala/Capronia species. Additionally, we applied the phylophenetic conceptual framework to delineate the species-specific hypothesis in order to incorporate this proposal within an integrative taxonomic framework. We believe that this approach to delimit fungal species will also be useful to our peers.


Sujet(s)
Ascomycota , Exophiala , Humains , Exophiala/génétique , Saccharomyces cerevisiae , Phylogenèse , Mexique , Théorème de Bayes
3.
Med Mycol ; 61(8)2023 Aug 02.
Article de Anglais | MEDLINE | ID: mdl-37591630

RÉSUMÉ

In cystic fibrosis (CF) patients, fungal colonization of the respiratory tract is frequently found. Aspergillus fumigatus, Scedosporium genus, and Exophiala dermatitidis are the most commonly isolated moulds from the respiratory tract secretions of CF patients. The aim of this 5-year surveillance study was to identify trends in species distribution and susceptibility patterns of 212 mould strains identified as Aspergillus spp., Scedosporium spp., and Exophiala spp., isolated from sputum of 63 CF patients who received long-term therapy with itraconazole (ITR) and/or voriconazole (VRC). The Aspergillus isolates were identified as members of the sections Fumigati (n = 130), Flavi (n = 22), Terrei (n = 20), Nigri (n = 8), Nidulantes (n = 1), and Usti (n = 1). Among the 16 species of the genus Scedosporium, 9 were S. apiospermum, 3 S. aurantiacum, and 4 S. boydii. Among the 14 Exophiala species, all were molecularly identified as E. dermatitidis. Overall, 94% (15/16) of Scedosporium spp., 50% (7/14) of E. dermatitidis, and 7.7% (14/182) of Aspergillus spp. strains showed high MIC values (≥8 µg/ml) for at least one antifungal. Particularly, 8.9% (19/212) of isolates showed high MIC values for amphotericin B, 11.7% (25/212) for ITR, 4.2% (9/212) for VRC, and 3.3% (7/212) for posaconazole. In some cases, such as some A. fumigatus and E. dermatitidis isolates recovered from the same patient, susceptibility to antifungal azoles decreased over time. We show that the use of azoles for a long time in CF patients causes the selection/isolation of mould strains with higher MIC values.


The use of azoles for a long time in cystic fibrosis patients causes the selection/isolation of Aspergillus, Scedosporium, and Exophiala species with higher MIC values.


Sujet(s)
Mucoviscidose , Exophiala , Scedosporium , Animaux , Antifongiques/pharmacologie , Antifongiques/usage thérapeutique , Amphotéricine B/pharmacologie , Amphotéricine B/usage thérapeutique , Mucoviscidose/complications , Mucoviscidose/médecine vétérinaire , Exophiala/génétique , Triazoles/pharmacologie , Triazoles/usage thérapeutique , Itraconazole , Voriconazole/pharmacologie , Voriconazole/usage thérapeutique , Aspergillus , Azoles
4.
Mycoses ; 66(6): 488-496, 2023 Jun.
Article de Anglais | MEDLINE | ID: mdl-36740746

RÉSUMÉ

BACKGROUND: The skin is the first line of defence against communities of resident viruses, bacteria and fungi. The composition of the microbiome might change with factors related to the environment and host. The microbiome is dominated by bacteria. Dermatophytes and yeasts are the predominant fungi that are also involved in opportunistic infections of skin, hair and nails. Among environmental fungi, Chaetothyriales (black yeasts and relatives) are enriched by hydrocarbon pollution in domesticated habitats and comprise numerous species that cause mild-to-severe disease. METHODS: We investigated the presence of black fungi in the skin microbiome by conducting an analysis in the publicly available metagenomic SRA database (NCBI). We focused on the causative agents of chromoblastomycosis and phaeohyphomycosis and used barcodes and padlock probe sequences as diagnostic tools. RESULTS: A total of 132,159,577 MB was analysed and yielded 18,360 reads that matched with 24 species of black fungi. Exophiala was the most prevalent genus, and Cyphellophora europaea was the most abundant species. CONCLUSION: This study reveals the abundant presence of Chaetothyriales on the skin without necessarily being associated with infection. Most of the detected causal agents are known from mild skin diseases, while also species were revealed that had been reported from CARD9-deficient patients.


Sujet(s)
Exophiala , Microbiote , Humains , Saccharomyces cerevisiae , Métagénomique , Peau/microbiologie , Exophiala/génétique , Microbiote/génétique , Champignons/génétique
5.
Nat Prod Res ; 35(15): 2598-2601, 2021 Aug.
Article de Anglais | MEDLINE | ID: mdl-31674836

RÉSUMÉ

Three pregnene steroids, two of them new, were isolated from ethyl-acetate partition of liquid-cultivation of the extremophyle fungus Exophiala oligosperma, found in a pH 1.5 hydrochloric acid aqueous solution. Spectroscopic studies using NMR and HRMS, allowed the identification of the molecular structures of both Δ8,9-pregnenes, still not described in the literature.


Sujet(s)
Exophiala/composition chimique , Extrêmophiles , Prégnènes/composition chimique , Stéroïdes/composition chimique , Champignons , Prégnènes/isolement et purification , Stéroïdes/isolement et purification
6.
PLoS One ; 15(5): e0229630, 2020.
Article de Anglais | MEDLINE | ID: mdl-32401759

RÉSUMÉ

Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis caused by traumatic implantation of many species of black fungi. Due to the refractoriness of some cases and common recurrence of CBM, a more effective and less time-consuming treatment is mandatory. The aim of this study was to identify compounds with in vitro antifungal activity in the Pathogen Box® compound collection against different CBM agents. Synergism of these compounds with drugs currently used to treat CBM was also assessed. An initial screening of the drugs present in this collection at 1 µM was performed with a Fonsecaea pedrosoi clinical strain according to the EUCAST protocol. The compounds with activity against this fungus were also tested against other seven etiologic agents of CBM (Cladophialophora carrionii, Phialophora verrucosa, Exophiala jeanselmei, Exophiala dermatitidis, Fonsecaea monophora, Fonsecaea nubica, and Rhinocladiella similis) at concentrations ranging from 0.039 to 10 µM. The analysis of potential synergism of these compounds with itraconazole and terbinafine was performed by the checkerboard method. Eight compounds inhibited more than 60% of the F. pedrosoi growth: difenoconazole, bitertanol, iodoquinol, azoxystrobin, MMV688179, MMV021013, trifloxystrobin, and auranofin. Iodoquinol produced the lowest MIC values (1.25-2.5 µM) and MMV688179 showed MICs that were higher than all compounds tested (5 - >10 µM). When auranofin and itraconazole were tested in combination, a synergistic interaction (FICI = 0.37) was observed against the C. carrionii isolate. Toxicity analysis revealed that MMV021013 showed high selectivity indices (SI ≥ 10) against the fungi tested. In summary, auranofin, iodoquinol, and MMV021013 were identified as promising compounds to be tested in CBM models of infection.


Sujet(s)
Antifongiques/pharmacologie , Chromoblastomycose/traitement médicamenteux , Synergie des médicaments , Champignons/pathogénicité , Acétates/pharmacologie , Ascomycota/effets des médicaments et des substances chimiques , Ascomycota/pathogénicité , Auranofine/pharmacologie , Dérivés du biphényle/pharmacologie , Chromoblastomycose/microbiologie , Chromoblastomycose/anatomopathologie , Dioxolanes/pharmacologie , Exophiala/effets des médicaments et des substances chimiques , Exophiala/pathogénicité , Champignons/effets des médicaments et des substances chimiques , Humains , Imines/pharmacologie , Diiodohydroxyquinoléine/pharmacologie , Pyrimidines/pharmacologie , Strobilurines/pharmacologie , Triazoles/pharmacologie
7.
Arch. argent. pediatr ; 118(1): 73-74, 2020-02-00. ilus
Article de Espagnol | LILACS, BINACIS | ID: biblio-1096192
8.
J Clin Immunol ; 40(2): 359-366, 2020 02.
Article de Anglais | MEDLINE | ID: mdl-31940125

RÉSUMÉ

PURPOSE: Caspase-associated recruitment domain-9 (CARD9) deficiency is an inborn error of immunity that typically predisposes otherwise healthy patients to single fungal infections and the occurrence of multiple invasive fungal infections is rare. It has been described as the first known condition that predisposes to extrapulmonary Aspergillus infection with preserved lungs. We present a patient that expands the clinical variability of CARD9 deficiency. MATERIALS AND METHODS: Genetic analysis was performed by Sanger sequencing. Neutrophils and mononuclear phagocyte response to fungal stimulation were evaluated through luminol-enhanced chemiluminescence and whole blood production of the proinflammatory mediator interleukin (IL)-6, respectively. RESULTS: We report a 56-year-old Argentinean woman, whose invasive Exophiala spinifera infection at the age of 32 years was unexplained and reported in year 2004. At the age of 49 years, she presented with chronic pulmonary disease due to Aspergillus nomius. After partial improvement following treatment with caspofungin and posaconazole, right pulmonary bilobectomy was performed. Despite administration of multiple courses of antifungals, sustained clinical remission could not be achieved. We recently found that the patient's blood showed an impaired production of IL-6 when stimulated with zymosan. We also found that she is homozygous for a previously reported CARD9 loss-of-function mutation (Q289*). CONCLUSIONS: This is the first report of a patient with inherited CARD9 deficiency and chronic invasive pulmonary aspergillosis (IPA) due to A. nomius. Inherited CARD9 deficiency should be considered in otherwise healthy children and adults with one or more invasive fungal diseases.


Sujet(s)
Aspergillus/physiologie , Protéines adaptatrices de signalisation CARD/génétique , Candidose mucocutanée chronique/diagnostic , Exophiala/physiologie , Mutation/génétique , Phaeohyphomycose/diagnostic , Aspergillose pulmonaire/diagnostic , Candidose mucocutanée chronique/génétique , Cellules cultivées , Femelle , Humains , Interleukine-6/métabolisme , Adulte d'âge moyen , Pedigree , Phaeohyphomycose/génétique , Pneumonectomie , Aspergillose pulmonaire/génétique
9.
Rev. colomb. nefrol. (En línea) ; 6(1): 63-68, ene.-jun. 2019. tab, graf
Article de Espagnol | LILACS, COLNAL | ID: biblio-1093027

RÉSUMÉ

Resumen Las micosis por Exophiala xenobiotica comprenden un amplio espectro clínico en pacientes inmunosuprimidos, desde infecciones localizadas, hasta diseminadas. Son incluidas como etiología de las feohifomicosis, actualmente consideradas como infecciones fúngicas emergentes en pacientes trasplantados de órgano sólido. Presentamos 2 casos de micosis por Eexophiala xenobiotica en paciente trasplantado renal, una micosis cutánea localizada y una infección sistémica con afectación del sistema nervioso central.


Abstract Mycosis by exophiala xenobiotica comprise a broad clinical spectrum in immunosuppressed patients, from localized to disseminated infections. They are a recognized etiology of phaeohyphomycosis, currently considered as emerging fungal infections in transplanted solid organ recipients. We present 2 cases of mycosis by exophiala xenobiotica in kidney transplant recipients, a localized cutaneous mycosis and a systemic infection with central nervous system involvement.


Sujet(s)
Humains , Mâle , Femelle , Exophiala , Transplantation rénale , Mycoses , Espagne , Amphotéricine B , Itraconazole , Phaeohyphomycose
10.
Rev Chil Pediatr ; 89(4): 506-510, 2018 Aug.
Article de Anglais, Espagnol | MEDLINE | ID: mdl-30571825

RÉSUMÉ

INTRODUCTION: Tinea nigra is a superficial mycosis caused by Hortaea werneckii. Its clinical characte ristic is the appearance of a blackish brown macula of rapid growth, caused by the pigment produced by the fungus itself. The presence of a dark, fast growing, acral pigmentary lesion causes concern among patients and their treating physician about the possibility of a malignant pigmentary lesion. OBJECTIVE: To present a series of three clinical cases in pediatric patients with this pathology and to show the tools that help to make a differential diagnosis. CLINICAL CASES: Three patients between three and five years of age, which present a macular pigmented lesion on palms or soles, whose parents reported a rapid growth over a short period of time. Two of the patients reported previous trips to the Caribbean. Clinical and dermatoscopy suspicion of tinea nigra lead to a direct mycological exa mination, which confirmed the diagnosis. In all three cases, treatment with topical antifungals led to complete healing of the lesions. CONCLUSIONS: Although tinea nigra is rare in a dry climate, increasing travel of patients to tropical countries will increase the number of cases. Dermatoscopy and direct mycological examination are the tools that allow performing a correct diagnosis and avoiding unne cessary biopsies and/or surgeries.


Sujet(s)
Exophiala/isolement et purification , Phaeohyphomycose/diagnostic , Teigne/diagnostic , Enfant d'âge préscolaire , Diagnostic différentiel , Humains , Mâle , Phaeohyphomycose/microbiologie , Teigne/microbiologie
11.
Rev. chil. pediatr ; 89(4): 506-510, ago. 2018. graf
Article de Espagnol | LILACS | ID: biblio-959553

RÉSUMÉ

Resumen: Introducción: La tiña negra es una micosis superficial causada por Hortaea werneckii. Su caracte rística clínica es la aparición de una mácula café negruzca de rápido crecimiento, producto del pig mento sintetizado por el mismo hongo. Sus características pigmentarias y de rápido crecimiento, de localización preferentemente acral, genera preocupación en los pacientes y en sus médicos tratantes por la sospecha de una lesion névica en evolución. Objetivos: Presentar 3 casos clínicos de pacientes pediátricos con esta patología y dar a conocer las herramientas para su diagnóstico diferencial. Casos clínicos: Tres pacientes, edades 3 y 5 años, con lesión macular pigmentada en palmas o plantas, cuyos padres referían habían crecido en forma rápida en poco tiempo. Dos de los casos tenían antecedentes de viajes previos al Caribe. Ante la sospecha clínica y dermatoscópica de una tiña negra, se realizó exámen micológico que confirmó el diagnóstico. En todos los casos, el tratamiento con antimicóticos tópicos llevó a la resolución completa de las lesiones. Conclusión: Aunque la tiña negra es rara en un clima seco, los viajes cada vez más frecuentes de los pacientes a países tropicales, probablemente aumentarán el número de casos. La dermatoscopía y el examen micológico son las herramientas que permiten realizar un correcto diagnóstico, evitando biopsias y/o cirugías innecesarias.


Abstract: Introduction: Tinea nigra is a superficial mycosis caused by Hortaea werneckii. Its clinical characte ristic is the appearance of a blackish brown macula of rapid growth, caused by the pigment produced by the fungus itself. The presence of a dark, fast growing, acral pigmentary lesion causes concern among patients and their treating physician about the possibility of a malignant pigmentary lesion. Objective: To present a series of three clinical cases in pediatric patients with this pathology and to show the tools that help to make a differential diagnosis. Clinical cases: Three patients between three and five years of age, which present a macular pigmented lesion on palms or soles, whose parents reported a rapid growth over a short period of time. Two of the patients reported previous trips to the Caribbean. Clinical and dermatoscopy suspicion of tinea nigra lead to a direct mycological exa mination, which confirmed the diagnosis. In all three cases, treatment with topical antifungals led to complete healing of the lesions. Conclusions: Although tinea nigra is rare in a dry climate, increasing travel of patients to tropical countries will increase the number of cases. Dermatoscopy and direct mycological examination are the tools that allow performing a correct diagnosis and avoiding unne cessary biopsies and/or surgeries.


Sujet(s)
Humains , Mâle , Enfant d'âge préscolaire , Teigne/diagnostic , Exophiala/isolement et purification , Phaeohyphomycose/diagnostic , Teigne/microbiologie , Diagnostic différentiel , Phaeohyphomycose/microbiologie
12.
Mycopathologia ; 182(11-12): 997-1004, 2017 Dec.
Article de Anglais | MEDLINE | ID: mdl-28660465

RÉSUMÉ

Since 1997, an emergent fungal disease named lethargic crab disease (LCD) has decimated stocks of the edible mangrove land crab Ucides cordatus (Linnaeus, 1763) (Brachyura: Ocypodidae) along the Brazilian coast, threatening the mangrove ecosystem and causing socioeconomic impacts. Evidence from a variety of sources suggests that the black yeast Exophiala cancerae (Herpotrichiellaceae, Chaetothyriales) has been responsible for such epizootic events. Based on the spatiotemporal patterns of the LCD outbreaks, the well-established surface ocean currents, and the range of ecological traits of Exophiala spp., a marine dispersal hypothesis may be proposed. Using in vitro experiments, we tested the survival and growth of E. cancerae CBS 120420 in a broad combination of salinities, temperatures, and exposure times. While variation in salinity did not significantly affect the growth of colony-forming units (CFUs) (P > 0.05), long exposure times visibly influenced an increase in CFUs growth (P < 0.05). However, higher temperature (30 °C) caused a reduction of about 1.2-fold in CFUs growth (P < 0.05). This result suggests that sea surface temperatures either above or below the optimum growth range of E. cancerae could play a key role in the apparent north-south limits in the geographical distribution of LCD outbreaks. In light of our results, we conclude that a fundamental step toward the understanding of LCD epidemiological dynamics should comprise a systematic screening of E. cancerae in estuarine and coastal waters.


Sujet(s)
Brachyura/microbiologie , Épidémies de maladies/médecine vétérinaire , Exophiala/croissance et développement , Phaeohyphomycose/épidémiologie , Phaeohyphomycose/transmission , Produits de la mer/microbiologie , Animaux , Brésil/épidémiologie , Exophiala/pathogénicité , Géographie , Océans et mers/épidémiologie , Phaeohyphomycose/microbiologie , Phaeohyphomycose/médecine vétérinaire , Salinité , Produits de la mer/économie , Température
13.
Braz. J. Microbiol. ; 48(1): 32-36, jan.-mar. 2017. tab, ilus
Article de Anglais | VETINDEX | ID: vti-22719

RÉSUMÉ

Actinobacteria occur in many environments and have the capacity to produce secondary metabolites with antibiotic potential. Identification and taxonomy of actinobacteria that produce antimicrobial substances is essential for the screening of new compounds, and sequencing of the 16S region of ribosomal DNA (rDNA), which is conserved and present in all bacteria, is an important method of identification. Melanized fungi are free-living organisms, which can also be pathogens of clinical importance. This work aimed to evaluate growth inhibition of melanized fungi by actinobacteria and to identify the latter to the species level. In this study, antimicrobial activity of 13 actinobacterial isolates from the genus Streptomyces was evaluated against seven melanized fungi of the genera Exophiala, Cladosporium, and Rhinocladiella. In all tests, all actinobacterial isolates showed inhibitory activity against all isolates of melanized fungi, and only one actinobacterial isolate had less efficient inhibitory activity. The 16S rDNA region of five previously unidentified actinobacterial isolates from Ilha do Mel, Paraná, Brazil, was sequenced; four of the isolates were identified as Streptomyces globisporus subsp. globisporus, and one isolate was identified as Streptomyces aureus. This work highlights the potential of actinobacteria with antifungal activity and their role in the pursuit of novel antimicrobial substances.(AU)


Sujet(s)
Antifongiques , Exophiala , Cladosporium , Actinobacteria/classification , Actinobacteria/génétique , Analyse de séquence d'ARN , Lutte biologique contre les nuisibles , Antibactériens
14.
Mycoses ; 60(5): 328-337, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-28139861

RÉSUMÉ

The Exophiala genus is responsible for many superficial and invasive infections resulting from black fungi. Identification of Exophiala at the species level is based on morphological observations complemented by molecular tests. The aim of this study was to identify 23 clinical isolates of Exophiala spp. and evaluate the antifungal susceptibility to seven different agents. Molecular identification was based on an analysis of ITS region of rDNA using genomic databases. The micromorphology was evaluated by microculture and scanning electron microscopy. The susceptibility tests were performed using the antifungal agents 5-fluorocytosine (5-FC), amphotericin B (AMB), itraconazole (ITC), voriconazole (VRC), posaconazole (PSC), caspofungin (CFG) and terbinafine (TRB). The ITS analysis identified 100% of the following isolates as: E. dermatitidis (8), E. xenobiotica (6), E. bergeri (4), E. oligosperma (3), E. spinifera (1) and E. mesophila (1). The antifungal susceptibility tests showed that the triazoles compounds were in vitro the most active agents against Exophiala. ITS sequencing enabled the accurate identification of the 23 tested isolates. The triazoles, particularly itraconazole and posaconazole, exhibited MIC values lower than AMB, CAS and 5-FC. Although the guidelines do not indicate AMB for treatment against Exophiala spp., this study showed activity for all of the tested species, except E. mesophila.


Sujet(s)
Antifongiques/pharmacologie , Exophiala/effets des médicaments et des substances chimiques , Exophiala/génétique , Variation génétique , Phaeohyphomycose/microbiologie , Adolescent , Adulte , Sujet âgé , Amphotéricine B/pharmacologie , Brésil/épidémiologie , Caspofungine , Enfant , Enfant d'âge préscolaire , Espaceur de l'ADN ribosomique/génétique , Échinocandines/pharmacologie , Exophiala/classification , Exophiala/ultrastructure , Femelle , Génotype , Humains , Itraconazole/pharmacologie , Lipopeptides/pharmacologie , Mâle , Tests de sensibilité microbienne , Microscopie électronique à balayage , Adulte d'âge moyen , Phaeohyphomycose/sang , Phaeohyphomycose/épidémiologie , Phénotype
15.
Clin Microbiol Infect ; 23(5): 333.e9-333.e14, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-28062320

RÉSUMÉ

OBJECTIVES: This is a retrospective and observational study addressing clinical and therapeutic aspects of melanized fungal infections in kidney transplant recipients. METHODS: We retrospectively reviewed medical records of all patients admitted between January 1996 and December 2013 in a single institution who developed infections by melanized fungi. RESULTS: We reported on 56 patients aged between 30 and 74 years with phaeohyphomycosis or chromoblastomycosis (0.54 cases per 100 kidney transplants). The median time to diagnosis post-transplant was 31.2 months. Thirty-four (60.8%) infections were reported in deceased donor recipients. Fifty-one cases of phaeohyphomycosis were restricted to subcutaneous tissues, followed by two cases with pneumonia and one with brain involvement. Most dermatological lesions were represented by cysts (23/51; 45.1%) or nodules (9/51; 17.9%). Exophiala spp. (34.2%) followed by Alternaria spp. (7.9%) were the most frequent pathogens. Graft loss and death occurred in two patients and one patient, respectively. Regarding episodes of subcutaneous phaeohyphomycosis, a complete surgical excision without antifungal therapy was possible in 21 of 51 (41.2%) patients. Long periods of itraconazole were required to treat the other 30 (58.8%) episodes of subcutaneous disease. All four cases of chromoblastomycosis were treated only with antifungal therapy. CONCLUSIONS: Melanized fungal infections should be considered in the differential diagnosis of all chronic skin lesions in transplant recipients. It is suggested that the impact of these infections on graft function and mortality is low. The reduction in immunosuppression should be limited to severely ill patients.


Sujet(s)
Chromoblastomycose/diagnostic , Chromoblastomycose/traitement médicamenteux , Transplantation rénale , Phaeohyphomycose/diagnostic , Phaeohyphomycose/traitement médicamenteux , Adulte , Sujet âgé , Alternaria/effets des médicaments et des substances chimiques , Alternaria/isolement et purification , Antifongiques/usage thérapeutique , Exophiala/effets des médicaments et des substances chimiques , Exophiala/isolement et purification , Femelle , Études de suivi , Humains , Itraconazole/usage thérapeutique , Mâle , Adulte d'âge moyen , Études rétrospectives , Receveurs de transplantation
16.
Mycoses ; 60(2): 129-135, 2017 Feb.
Article de Anglais | MEDLINE | ID: mdl-27766680

RÉSUMÉ

Mycetoma is a chronic granulomatous, subcutaneous disease endemic in tropical and subtropical countries. It is currently a health problem in rural areas of Africa, Asia and South America. Nine cases of mycetoma were analysed in a retrospective study. All isolates were identified by morphological features. The level of species identification was reached by molecular tools. Definitive identification of fungi was performed using sequence analysis of the ITS of the ribosomal DNA region and the ribosomal large-subunit D1/D2. Identification of actinomycetes was accomplished by the 16S rRNA gene sequence. Six unusual clinical isolates were identified: Aspergillus ustus, Cyphellophora oxyspora, Exophiala oligosperma, Madurella pseudomycetomatis, Nocardia farcinica and Nocardia wallacei. The prevalence of mycetoma in Venezuela remains unknown. This study represents the first report in the literature of mycetoma caused by unusual pathogens identified by molecular techniques.


Sujet(s)
Actinomycetales/génétique , Espaceur de l'ADN ribosomique , ADN ribosomique/génétique , Champignons/génétique , Mycétome/microbiologie , ARN ribosomique 16S/génétique , Actinobacteria/génétique , Actinomycetales/isolement et purification , Adolescent , Adulte , Exophiala/génétique , Exophiala/isolement et purification , Femelle , Champignons/classification , Champignons/isolement et purification , Humains , Madurella/génétique , Madurella/isolement et purification , Mâle , Adulte d'âge moyen , Mycétome/traitement médicamenteux , Mycétome/épidémiologie , Mycétome/anatomopathologie , Techniques de typage mycologique , Nocardia/génétique , Nocardia/isolement et purification , Études rétrospectives , Tomodensitométrie , Venezuela/épidémiologie
17.
Clin Microbiol Rev ; 30(1): 233-276, 2017 01.
Article de Anglais | MEDLINE | ID: mdl-27856522

RÉSUMÉ

Chromoblastomycosis (CBM), also known as chromomycosis, is one of the most prevalent implantation fungal infections, being the most common of the gamut of mycoses caused by melanized or brown-pigmented fungi. CBM is mainly a tropical or subtropical disease that may affect individuals with certain risk factors around the world. The following characteristics are associated with this disease: (i) traumatic inoculation by implantation from an environmental source, leading to an initial cutaneous lesion at the inoculation site; (ii) chronic and progressive cutaneous and subcutaneous tissular involvement associated with fibrotic and granulomatous reactions associated with microabscesses and often with tissue proliferation; (iii) a nonprotective T helper type 2 (Th2) immune response with ineffective humoral involvement; and (iv) the presence of muriform (sclerotic) cells embedded in the affected tissue. CBM lesions are clinically polymorphic and are commonly misdiagnosed as various other infectious and noninfectious diseases. In its more severe clinical forms, CBM may cause an incapacity for labor due to fibrotic sequelae and also due to a series of clinical complications, and if not recognized at an early stage, this disease can be refractory to antifungal therapy.


Sujet(s)
Chromoblastomycose/épidémiologie , Exophiala/classification , Maladies professionnelles/microbiologie , Antifongiques/usage thérapeutique , Chromoblastomycose/traitement médicamenteux , Chromoblastomycose/immunologie , Prise en charge de la maladie , Multirésistance des champignons aux médicaments , Humains , Maladies négligées/épidémiologie , Maladies négligées/immunologie , Maladies négligées/microbiologie , Maladies professionnelles/épidémiologie , Phylogenèse
18.
Mycopathologia ; 181(5-6): 353-62, 2016 Jun.
Article de Anglais | MEDLINE | ID: mdl-27028446

RÉSUMÉ

Several species of the genus Exophiala are found as opportunistic pathogens on humans, while others cause infections in cold-blooded waterborne vertebrates. Opportunism of these fungi thus is likely to be multifactorial. Ecological traits [thermotolerance and pH tolerance, laccase activity, assimilation of mineral oil, and decolorization of Remazol Brilliant Blue R (RBBR)] were studied in a set of 40 strains of mesophilic Exophiala species focused on the salmonis-clade mainly containing waterborne species. Thermophilic species and waterborne species outside the salmonis-clade were included for comparison. Strains were able to tolerate a wide range of pHs, although optimal growth was observed between pH 4.0 and 5.5. All strains tested were laccase positive. Strains were able to grow in the presence of the compounds (mineral oil and RBBR) with some differences in assimilation patterns between strains tested and also were capable of degrading the main chromophore of RBBR. The study revealed that distantly related mesophilic species behave similarly, and no particular trend in evolutionary adaptation was observed.


Sujet(s)
Exophiala/isolement et purification , Exophiala/physiologie , Mycoses/microbiologie , Mycoses/médecine vétérinaire , Infections opportunistes/microbiologie , Infections opportunistes/médecine vétérinaire , Animaux , Anthraquinones/métabolisme , Exophiala/croissance et développement , Exophiala/métabolisme , Humains , Concentration en ions d'hydrogène , Laccase/analyse , Huile minérale/métabolisme , Vertébrés
19.
An Bras Dermatol ; 91(1): 89-92, 2016.
Article de Anglais | MEDLINE | ID: mdl-26982786

RÉSUMÉ

Phaeohyphomycosis is an infection caused by a filamentous fungus that contains pigment melanin in its cell wall. We report two cases caused by Exophiala sp. emphasizing the clinical variability of the disease, as well as diagnostic and therapeutic difficulties of this opportunistic infection in immunosuppressed patients (kidney transplant).


Sujet(s)
Exophiala/isolement et purification , Transplantation rénale/effets indésirables , Phaeohyphomycose/anatomopathologie , Antifongiques/usage thérapeutique , Humains , Sujet immunodéprimé , Immunosuppresseurs/effets indésirables , Mâle , Adulte d'âge moyen , Infections opportunistes/immunologie , Infections opportunistes/anatomopathologie , Infections opportunistes/thérapie , Phaeohyphomycose/immunologie , Phaeohyphomycose/thérapie , Peau/anatomopathologie
20.
An. bras. dermatol ; An. bras. dermatol;91(1): 89-92, Jan.-Feb. 2016. graf
Article de Anglais | LILACS | ID: lil-776416

RÉSUMÉ

Abstract Phaeohyphomycosis is an infection caused by a filamentous fungus that contains pigment melanin in its cell wall. We report two cases caused by Exophiala sp. emphasizing the clinical variability of the disease, as well as diagnostic and therapeutic difficulties of this opportunistic infection in immunosuppressed patients (kidney transplant).


Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Exophiala/isolement et purification , Transplantation rénale/effets indésirables , Phaeohyphomycose/anatomopathologie , Antifongiques/usage thérapeutique , Sujet immunodéprimé , Immunosuppresseurs/effets indésirables , Infections opportunistes/immunologie , Infections opportunistes/anatomopathologie , Infections opportunistes/thérapie , Phaeohyphomycose/immunologie , Phaeohyphomycose/thérapie , Peau/anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE